FLT3 and leukemia: Our previous study demonstrated that USP9X inhibition in FLT3-ITD-positive AML induced the K63-Ub processing of receptor-type tyrosine kinases to form aggresomes [34], suggesting a rapid removal mechanism for the misfolded proteins in leukemia cells.